MRSA recurrence, resistance and genomic epidemiology
Andrew Page speaks with Brooke Talbot, a recent PhD graduate from Emory University, about the molecular epidemiology of Staphylococcus aureus and MRSA. They discuss how comparisons between bacterial genomes can help investigate recurrent bloodstream infections, and why sampling a single colony may miss important diversity. Talbot also traces her route from honeybee research to foodborne illness surveillance and using genomic data for public health decisions.
Listen to Episode 134: Diving into MRSA, Genomics, and Public Health on SoundCloud
In this episode
MRSA lineages in the US and UK
Speaking at a hackathon in Bethesda, Maryland, Brooke Talbot introduces her research on the molecular epidemiology of bacterial infections. Her laboratory’s main focus is Staphylococcus aureus, and her PhD work examined strains with methicillin resistance, commonly known as MRSA.
Talbot describes USA300 as a common lineage in the United States and tentatively places its expansion in the 1990s. Andrew Page contrasts this with EMRSA-15, which he describes as dominant in the UK. Their discussion distinguishes different bacterial lineages from differences in naming. Page also raises vancomycin-resistant S. aureus, moving the conversation from methicillin resistance to the broader problem of bacteria becoming resistant to drugs used to treat them.
Resistance can develop within a patient
Talbot notes that antibiotic resistance has been described as a silent epidemic, and connects the problem to stewardship, detection and changes that occur after an initial culture. Her concern is not only the spread of an already resistant strain: bacteria persisting on a patient may also change during treatment.
She gives the example of a patient treated for an infection whose bacteria persist and later recur with resistance to the drug previously used. In that situation, a new resistance pattern need not mean that the patient acquired an entirely new bacterial strain from elsewhere. Following changes over time therefore matters alongside identifying the initial infection.
Talbot is careful about the limits of her experience. She does not offer a formal clinical definition of multidrug resistance and says she has not encountered extensively drug-resistant staph in the sample sets she has worked with, without claiming that it is absent elsewhere.
Comparing recurrent bloodstream infections
One of Talbot’s studies examines recurrent bloodstream infections caused by MRSA. Rather than sampling multiple body sites, this work uses isolates from blood collected at different times from the same patient. She compares their genomes using single nucleotide polymorphism counting, or SNP counting, to assess how closely related they are.
Very small genetic distances support the possibility that successive isolates came from the same bacterial source population, rather than representing unrelated infections acquired around the hospital. That still leaves an important question: did the bacteria persist on the patient, or did someone close to them provide a source of reinfection?
Talbot also examines where genomic changes occur, including mutations in antibiotic resistance-associated genes in later isolates. She asks whether reinfection from an untreated housemate is biologically plausible when the changes are associated with antibiotic resistance. This strengthens a hypothesis of host-associated persistence, rather than proving where the bacteria remained.
What a single colony can miss
Page asks whether apparent differences between isolates could arise simply because a different colony was selected from the bacterial population on a plate. Talbot agrees that colony selection can capture different parts of the diversity present in a patient’s bacteria. One isolate may therefore look different from another collected from the same patient.
She discusses looking at several colonies to get a better sense of that diversity, rather than relying on one colony alone. She refers to work exploring how much sampling is needed, but does not give a fixed sampling target. Page points out the financial pressure to analyse only one isolate per patient. Talbot acknowledges those restrictions while saying that, in an ideal setting, she would favour as much sampling as possible.
From honeybee viruses to public health genomics
Talbot’s research extends beyond staph. During her PhD she also worked with metagenomics to look for antibiotic resistance genes. Her earlier interest in population biology began during undergraduate biology studies, investigating microbes affecting honeybee health. She describes viruses spread by mites that infect bees and cause deformed wings, and her interest in detecting their presence and following prevalence within and between hives.
She later completed a two-year epidemiology fellowship, working at New York City’s Department of Health on foodborne illness surveillance, including Salmonella. This was where she first encountered the practical use of genomic epidemiology in public health.
For Talbot, the appeal of bioinformatics is turning information and data into action. She describes work that can serve local communities, help the bioinformatics community approach research questions, and support public health and epidemiology decisions about how to use genomes.
Highlights
- 00:00:33 — Talbot introduces her molecular epidemiology research on Staphylococcus aureus and MRSA.
- 00:01:42 — Page contrasts UK EMRSA-15 with USA300 and asks about vancomycin resistance.
- 00:02:40 — Stewardship, persistent bacteria and resistance developing within a patient.
- 00:04:27 — A study of recurrent MRSA bloodstream infections uses isolates from blood.
- 00:04:46 — SNP counting compares successive isolates to assess clonal relatedness.
- 00:05:41 — Resistance-associated mutations help frame persistence versus reinfection hypotheses.
- 00:06:50 — Colony selection and the diversity that single-isolate sampling can miss.
- 00:09:44 — Talbot describes work beyond staph, beginning with metagenomics and resistance genes.
- 00:11:33 — A two-year epidemiology fellowship connects foodborne surveillance with genomic epidemiology.
- 00:12:24 — Talbot reflects on using bioinformatics data to serve research and public health communities.
In their own words
So I work primarily on the molecular epidemiology of bacterial infections.
— Brooke Talbot, 00:00:33
Who is talking
- Andrew Page (host)
- Brooke Talbot (guest, Emory University)
Questions this episode answers
How does Talbot use genomics to investigate recurrent MRSA infections?
She compares blood isolates collected from the same patient at different times using SNP counting. Closely related genomes support a shared bacterial source population, although they do not by themselves establish whether bacteria persisted on the patient or were acquired again from a close contact.
Why might researchers examine more than one bacterial colony per patient?
Talbot explains that different colonies can represent diversity within the patient’s bacterial population. Examining several colonies can reveal variation that a single isolate misses, although financial restrictions may limit sampling.
Which MRSA lineages are discussed in the episode?
Talbot discusses USA300 as a common US lineage and tentatively dates its expansion to the 1990s. Page contrasts it with EMRSA-15, which he describes as dominant in the UK.
What public health work did Brooke Talbot do before her PhD?
Talbot describes a two-year epidemiology fellowship working on foodborne illness surveillance at New York City’s Department of Health. That work introduced her to using genomic epidemiology in public health practice.
This page was written from a machine transcript of the episode and checked against it. Listen to the episode for the whole conversation.
Show notes
In this episode of the Micro Binfie Podcast, host Andrew Page speaks with Dr. Brooke Talbot, a recent PhD graduate from Emory University, about her research on Staphylococcus aureus, with a focus on MRSA and antibiotic resistance. Brooke shares insights into her molecular epidemiology work, discussing the complexities of tracking resistant bacterial strains in clinical settings and the significance of genomic epidemiology in public health. From honeybees to foodborne outbreaks, Brooke’s diverse research background offers listeners a fascinating journey through science, microbiology, and epidemiology.